Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dwarfism × Growth Hormone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Postoperative Complications 1 Polycystic Ovary Syndrome 1 Pituitary Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Metabolic Syndrome 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Insulin Resistance 1 Hypopituitarism 1 Dwarfism, Pituitary 1 Dwarfism 1 Atherosclerosis 1

Interventions

Growth Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01901666 2013-07-17

Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission

PIMERIndia

Phase 4 Unknown

MyeloidOther hematologic neoplasm

Dwarfism, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡